» Articles » PMID: 2660073

Regulation of Cell Cycle Duration by C-myc Levels

Overview
Journal Oncogene
Date 1989 Jun 1
PMID 2660073
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Early passage murine fibroblasts infected with retroviral vectors carrying human c-myc 'minigenes' express high levels of c-myc and have a dramatically shortened G1-phase of the cell cycle. Cells infected with viruses where c-myc is expressed from the viral LTR (MSN-4 virus) express more c-myc protein than cells infected with viruses where c-myc is expressed from the SV40 early promoter (NSM-7 virus). Populations of cells were infected with high titre viruses, selected for drug-resistance, pulse labelled with bromodeoxyuridine (BrdUrd) and chased in BrdUrd free media. This allows accurate, simultaneous, measurement of the rate of exit of unlabelled cells from G1 and progression of BrdUrd-labelled cells through S-phase. The length of the G1-phase in cell populations infected with the MSN-4 virus is 4.65 h, a reduction of nearly 30% compared to the G1-phase length of 6.50 h seen in cells infected with the VSN-2 control virus. Cells infected with NSM-7 virus show an intermediate phenotype and have a G1-phase of 5.25 h. The lengths of the S-phase (4.50 to 4.75 h) and G2 + M phases (2.75 h) were not significantly altered by exogenous c-myc expression. When chases are performed in growth-factor free media, the G1-phase of infected and non-infected cells is extended by approximately 2 h. Cells infected with the c-myc viruses continue to cycle more rapidly than uninfected cells. Growth factor-deprived cells, restimulated with serum, show similar alterations of the cell cycle kinetics. MSN-4 and NSM-7 infected cells, expressing high levels of c-myc, enter S-phase 2 to 4 h earlier, but less synchronously, than control cells, and sustain subsequent rounds of DNA synthesis, while control cells do not. However, cells carrying activated c-myc genes have nearly-normal morphologies and are not tumourgenic in syngenic mice. These results demonstrate that c-myc levels are rate limiting for events in G1, and the length of G1 varies proportionally with the level of exogenous c-myc expression.

Citing Articles

USP37 prevents unscheduled replisome unloading through MCM complex deubiquitination.

Bolhuis D, Fleifel D, Bonacci T, Wang X, Mouery B, Cook J bioRxiv. 2024; .

PMID: 39282338 PMC: 11398414. DOI: 10.1101/2024.09.03.610997.


LINC00460/miR-186-3p/MYC feedback loop facilitates colorectal cancer immune escape by enhancing CD47 and PD-L1 expressions.

Luo Q, Shen F, Zhao S, Dong L, Wei J, Hu H J Exp Clin Cancer Res. 2024; 43(1):225.

PMID: 39135122 PMC: 11321182. DOI: 10.1186/s13046-024-03145-1.


C16, a PKR inhibitor, suppresses cell proliferation by regulating the cell cycle via p21 in colorectal cancer.

Hashimoto Y, Tokumoto Y, Watanabe T, Ogi Y, Sugishita H, Akita S Sci Rep. 2024; 14(1):9029.

PMID: 38641657 PMC: 11031597. DOI: 10.1038/s41598-024-59671-7.


The MYC oncogene - the grand orchestrator of cancer growth and immune evasion.

Dhanasekaran R, Deutzmann A, Mahauad-Fernandez W, Hansen A, Gouw A, Felsher D Nat Rev Clin Oncol. 2021; 19(1):23-36.

PMID: 34508258 PMC: 9083341. DOI: 10.1038/s41571-021-00549-2.


The Role of Non-Coding RNAs in the Regulation of the Proto-Oncogene MYC in Different Types of Cancer.

Stasevich E, Murashko M, Zinevich L, Demin D, Schwartz A Biomedicines. 2021; 9(8).

PMID: 34440124 PMC: 8389562. DOI: 10.3390/biomedicines9080921.